Back
Product details:
CAS
104993-28-4
Purity
95%
Fondaparinux is an anticoagulant used to prevent venous thromboembolism, to treat deep vein thrombosis, and to improve survival following myocardial infarction. The antithrombotic activity of fondaparinux is the result of ATIII-mediated selective inhibition of Factor Xa.
Properties
Name
Fondaparinux
Smiles
CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)C(=O)O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)C(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O
Targets
Please log in to see this information
fondaparinux
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$151
2 mg
$180
5 mg
$324
10 mg
$531
15 mg
$661
20 mg
$751
25 mg
$887
30 mg
$1019
35 mg
$1183
40 mg
$1313
45 mg
$1445
50 mg
$1543
75 mg
$1944
100 mg
$2384
Quantity
1
Total amount
$ 324
fondaparinux
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.